These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27094604)

  • 21. An in vitro assay to measure targeted drug delivery to bone mineral.
    Jahnke W; Henry C
    ChemMedChem; 2010 May; 5(5):770-6. PubMed ID: 20209564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adding alendronate to ongoing hormone therapy on bone mineral density in postmenopausal Korean women: a randomized, double-blind, placebo-controlled clinical trial.
    Min YK; Lee DY; Choi SJ; Kim JH; Choi D; Yoon BK
    Menopause; 2013 Jul; 20(7):761-6. PubMed ID: 23403498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone-targeting carbon dots: effect of nitrogen-doping on binding affinity.
    Lee KK; Lee JG; Park CS; Lee SH; Raja N; Yun HS; Lee JS; Lee CS
    RSC Adv; 2019 Jan; 9(5):2708-2717. PubMed ID: 35520477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
    Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risedronate/zinc-hydroxyapatite based nanomedicine for osteoporosis.
    Khajuria DK; Disha C; Vasireddi R; Razdan R; Mahapatra DR
    Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():78-87. PubMed ID: 27040198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanodiamonds as novel nanomaterials for biomedical applications: drug delivery and imaging systems.
    Kaur R; Badea I
    Int J Nanomedicine; 2013; 8():203-20. PubMed ID: 23326195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.
    Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY
    Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis.
    Sultana S; Talegaonkar S; Ali R; Mittal G; Ahmad FJ; Bhatnagar A
    J Microencapsul; 2012; 29(5):445-54. PubMed ID: 22292965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated Osteogenic Differentiation of MC3T3-E1 Cells by Lactoferrin-Conjugated Nanodiamonds through Enhanced Anti-Oxidant and Anti-Inflammatory Effects.
    Kim SE; Choi S; Hong JY; Shim KS; Kim TH; Park K; Lee SH
    Nanomaterials (Basel); 2019 Dec; 10(1):. PubMed ID: 31878270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alendronate induces mineralization in mouse osteoblastic MC3T3-E1 cells: regulation of mineralization-related genes.
    Inoue Y; Hisa I; Seino S; Kaji H
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):719-23. PubMed ID: 20213600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherent anchorages in UiO-66 nanoparticles for efficient capture of alendronate and its mediated release.
    Zhu X; Gu J; Wang Y; Li B; Li Y; Zhao W; Shi J
    Chem Commun (Camb); 2014 Aug; 50(63):8779-82. PubMed ID: 24967656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancellous bone formation response to simulated resistance training during disuse is blunted by concurrent alendronate treatment.
    Swift JM; Swift SN; Nilsson MI; Hogan HA; Bouse SD; Bloomfield SA
    J Bone Miner Res; 2011 Sep; 26(9):2140-50. PubMed ID: 21509821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A preliminary study on the morphological and release properties of hydroxyapatite-alendronate composite materials.
    Capra P; Dorati R; Colonna C; Bruni G; Pavanetto F; Genta I; Conti B
    J Microencapsul; 2011; 28(5):395-405. PubMed ID: 21736524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comparative Study of Intravenous Injection Form and Oral Jelly Form of Alendronate Sodium Hydrate for Bone Mineral Disorder after Gastrectomy.
    Kunisaki C; Tanaka Y; Kosaka T; Miyamoto H; Sato S; Suematsu H; Yukawa N; Sato K; Izumisawa Y; Akiyama H; Taguri M; Yamanaka T; Endo I
    Digestion; 2017; 95(2):162-171. PubMed ID: 28214864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simulated resistance training, but not alendronate, increases cortical bone formation and suppresses sclerostin during disuse.
    Macias BR; Swift JM; Nilsson MI; Hogan HA; Bouse SD; Bloomfield SA
    J Appl Physiol (1985); 2012 Mar; 112(5):918-25. PubMed ID: 22174402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigations on the interactions between curcumin loaded vitamin E TPGS coated nanodiamond and Caco-2 cell monolayer.
    Liu D; Cheng B; Li D; Li J; Wu Q; Pan H
    Int J Pharm; 2018 Nov; 551(1-2):177-183. PubMed ID: 30223074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol.
    Takeda S; Kaneoka H; Saito T
    Mod Rheumatol; 2008; 18(3):271-6. PubMed ID: 18427724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteotropic therapy via targeted layer-by-layer nanoparticles.
    Morton SW; Shah NJ; Quadir MA; Deng ZJ; Poon Z; Hammond PT
    Adv Healthc Mater; 2014 Jun; 3(6):867-75. PubMed ID: 24124132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.
    Kusamori K; Katsumi H; Abe M; Ueda A; Sakai R; Hayashi R; Hirai Y; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.